Additional value of tumour growth rate (TGR) in patients (pts) diagnosed with well-differentiated neuroendocrine tumours (NETs) achieving RECIST-defined stable disease (SD): Subgroup analysis of the GREPONET study.
Lamarca Angela, Crona Joakim, Ronot Maxime, Opalinska Marta, Lopez Lopez Carlos, Pezzutti Daniela, Carvalho Luciana, Franca Regis, Najran Pavan, de Mestier Louis et al., 2018/05/20., 2018 ASCO Annual Meeting pp. 4094-4094 dans Journal of Clinical Oncology.
ici le détail